Research
UBS Downgrades Eyebright Medical Technology (Beijing) to Neutral from Buy; Price Target is 40 Yuan
Eyebright Medical Technology (Beijing) (SHA:688050) has an average rating of overweight and mean price target of 55.33 yuan, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
SHA:688050
